Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery

Journal of Drug Targeting

Volumn 19, Issue 3, 2011, Pages 197-203

  Shen, Jie ^a   Zhan, Changyou ^a   Xie, Cao ^a   Meng, Qinggang ^a   Gu, Bing ^a   Li, Chong ^a   Zhang, Yingkai ^a   Lu, Weiyue ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

angiopep; blood brain barrier; Brain targeting; near infrared fluorescence imaging; PEG PLA micelles

Indexed keywords

ANGIOPEP 2; FLUORESCENT DYE; IODINE 125; LIGAND; NANOCARRIER; POLY(ETHYLENE GLYCOL) BLOCK POLY(DEXTRO,LEVO LACTIDE ACID) MICELLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN TARGETING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EX VIVO STUDY; FLUORESCENCE IMAGING; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TRANSCYTOSIS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MALE; MICE; MICELLES; PEPTIDES; POLYETHYLENE GLYCOLS;

EID: 79952651973     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.483517     Document Type: Article

References (34)

1. Begley DJ, Brightman MW. (2003). Structural and functional aspects of the blood-brain barrier. Prog Drug Res, 61, 39-78. (Pubitemid 37187402)
2. Béduneau A, Saulnier P, Benoit JP. (2007). Active targeting of brain tumors using nanocarriers. Biomaterials, 28, 4947-4967. (Pubitemid 47362345)
3. Bickel U, Yoshikawa T, Pardridge WM. (2001). Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev, 46, 247-279.
4. Craparo EF, Ognibene MC, Casaletto MP, Pitarresi G, Teresi G, Giammona G. (2008). Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting. Nanotechnology, 19, 485603.
5. de Boer AG, Gaillard PJ. (2007). Strategies to improve drug delivery across the blood-brain barrier. Clin Pharmacokinet, 46, 553-576. (Pubitemid 47025357)
6. Demeule M, Régina A, Ché C, Poirier J, Nguyen T, Gabathuler R, Castaigne JP, Béliveau R. (2008a). Identifcation and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ter, 324, 1064-1072. (Pubitemid 351397849)
7. Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R. (2008b). Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem, 106, 1534-1544.
8. Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, Jiang X. (2009). Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release, 134, 55-61.
9. Huwyler J, Wu D, Pardridge WM. (1996). Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA, 93, 14164-14169. (Pubitemid 26424263)
10. Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C. (2009). Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modifed polyamidoamine dendrimer. Biomaterials, 30, 6976-6985.
11. Lesniak MS, Upadhyay U, Goodwin R, Tyler B, Brem H. (2005). Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res, 25, 3825-3831. (Pubitemid 41665151)
12. Liu L, Venkatraman SS, Yang YY, Guo K, Lu J, He B, Moochhala S, Kan L. (2008). Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Biopolymers, 90, 617-623.
13. Lu W, Wan J, She Z, Jiang X. (2007). Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release, 118, 38-53. (Pubitemid 46283096)
14. Miller G. (2002). Drug targeting. Breaking down barriers. Science, 297, 1116-1118. (Pubitemid 36193322)
15. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin SF, Sherry AD, Boothman DA, Gao J. (2006). Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett, 6, 2427-2430. (Pubitemid 46076928)
16. Ong BY, Ranganath SH, Lee LY, Lu F, Lee HS, Sahinidis NV, Wang CH. (2009). Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials, 30, 3189-3196.
17. Pardridge WM. (1999a). Blood-brain barrier biology and methodology. J Neurovirol, 5, 556-569. (Pubitemid 30032082)
18. Pardridge WM. (1999b). Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems. Pharm Sci Technol Today, 2, 49-59. (Pubitemid 29130313)
19. Pardridge WM. (2001). Crossing the blood-brain barrier: are we getting it right? Drug Discov Today, 6, 1-2. (Pubitemid 32164431)
20. Pardridge WM. (2005). Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. Neuro Rx, 2, 129-138. (Pubitemid 40128033)
21. Pardridge WM. (2007). Drug targeting to the brain. Pharm Res, 24, 1733-1744. (Pubitemid 47206623)
22. Rautio J, Chikhale PJ. (2004). Drug delivery systems for brain tumor therapy. Curr Pharm Des, 10, 1341-1353. (Pubitemid 38559751)
23. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. (1993). Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron, 11, 575-580. (Pubitemid 23321768)
24. Régina A, Demeule M, Ché C, Lavallée I, Poirier J, Gabathuler R, Béliveau R, Castaigne JP. (2008). Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol, 155, 185-197.
25. Shi N, Boado RJ, Pardridge WM. (2001). Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res, 18, 1091-1095. (Pubitemid 32900392)
26. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. (2000). Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest, 106, 1489-1499. (Pubitemid 32038587)
27. Soni S, Babbar AK, Sharma RK, Maitra A. (2006). Delivery of hydrophobised 5-fuorouracil derivative to brain tissue through intravenous route using surface modifed nanogels. J Drug Target, 14, 87-95.
28. Stolnik S, Heald CR, Neal J, Garnett MC, Davis SS, Illum L, Purkis SC, Barlow RJ, Gellert PR. (2001). Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance. J Drug Target, 9, 361-378. (Pubitemid 33094555)
29. Tomas FC, Taskar K, Rudraraju V, Goda S, Torsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS, Lockman PR, Smith QR. (2009). Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res, 26, 2486-2494.
30. Ulbrich K, Hekmatara T, Herbert E, Kreuter J. (2009). Transferrin-and transferrin-receptor-antibody-modifed nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm, 71, 251-256.
31. Visser CC, Voorwinden LH, Crommelin DJ, Danhof M, de Boer AG. (2004). Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res, 21, 761-769. (Pubitemid 39011297)
32. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z. (2003). A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncology, 5, 79-88. (Pubitemid 36422560)
33. Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M. (1997). Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas. Cancer Res, 57, 2799-2805. (Pubitemid 27283795)
34. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. (2001). Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. J Control Release, 77, 27-38. (Pubitemid 33022613)